Skip to Main Content

Paper Details

Validity and Characterization of Time to Symptom Resolution Outcome Measures in the ACTIV-2/A5401 Outpatient COVID-19 Treatment Trial.
J Infect Dis
0
2023
COVID-19, coronavirus disease 2019, participants
Author NameAffiliation
David A WohlUniversity of North Carolina at Chapel Hill
Eric S DaarThe Lundquist Institute, Harbor-University of California, Los Angeles Medical Center
Joseph J EronUniversity of North Carolina at Chapel Hill
Judith S CurrierDavid Geffen School of Medicine, University of California los angeles
Judith S CurrierDavid Geffen School of Medicine, University of California los angeles
  • 1 - 5

Datasets